Patel Sujal M 4
4 · Nautilus Biotechnology, Inc. · Filed Mar 7, 2024
Insider Transaction Report
Form 4
Patel Sujal M
DirectorCEO, President, and Secretary10% Owner
Transactions
- Purchase
Common Stock
2024-03-06$2.70/sh+9,267$25,034→ 10,031,160 total - Purchase
Common Stock
2024-03-05$2.65/sh+7,405$19,597→ 10,021,893 total - Purchase
Common Stock
2024-03-07$2.89/sh+18,854$54,424→ 10,050,014 total
Holdings
- 1,814,035(indirect: By Trust)
Common Stock
- 5,280,476(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]Represents the weighted average share price of an aggregate total of 7,405 shares purchased in the price range of $2.58 to $2.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 9,267 shares purchased in the price range of $2.64 to $2.77 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 18,854 shares purchased in the price range of $2.72 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F4]Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
- [F5]Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.